MACROGENICS, INC. Inventory, Raw Materials, Gross
MACROGENICS, INC. (MGNX) had Inventory, Raw Materials, Gross of $608.00 thousand as of 2021-09-30, per its 10-Q filed 2021-11-02.
Discontinued › Notes › Inventory
us-gaap:InventoryRawMaterials · last filed 2021-11-02
- 2021-09-30: Inventory, Raw Materials, Gross $608.00K.
- 2021-06-30: Inventory, Raw Materials, Gross $607.00K.
- 2021-03-31: Inventory, Raw Materials, Gross $1.22M.
| Period end | Inventory, Raw Materials, Gross |
|---|---|
| 2021-09-30 | $608.00K 10-Q · filed 2021-11-02 |
| 2021-06-30 | $607.00K 10-Q · filed 2021-07-29 |
| 2021-03-31 | $1.22M 10-Q · filed 2021-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |